astrazeneca pharma has strengthened its senior leadership with the appointment of two new Directors and the promotion of an existing executive. The Board of Directors approved the appointments of Mr. Mihir Parikh and Mr. Amay Ashok Pandey as Directors, alongside the elevation of Mr. Vinay Sharma to the role of Director. These strategic moves aim to bolster the company's commercial excellence and business unit leadership across key therapy areas including oncology and rare diseases.

The Board's decisions were based on the recommendations of the Nomination and Remuneration Committee. Mr. Mihir Parikh has been appointed as Director - Commercial Excellence, BD & Strategy, effective August 1, 2026. Mr. Amay Ashok Pandey takes on the role of Director – Oncology Business Unit, effective September 1, 2026. Furthermore, Mr. Vinay Sharma has been promoted to Director - Rare Diseases Business Unit from his previous position as Business Unit Head, effective August 1, 2026.

Leadership Profiles

The new appointees bring extensive experience in the pharmaceutical industry. Mr. Mihir Parikh is a biopharmaceutical commercial leader with over 15 years of experience in oncology marketing, sales leadership, and commercial strategy. He currently serves as the Breast Cancer Franchise Lead at AstraZeneca, a position he held since rejoining the organization in July 2025. His academic background includes studies at the Indian School of Business and Rutgers University.

Mr. Amay Ashok Pandey is a seasoned oncology commercial leader with nearly a decade of experience at AstraZeneca and over 18 years in the pharmaceutical industry. He currently serves as Head of Sales & Operations – Oncology based in Jakarta. Prior to joining AstraZeneca, he held leadership roles at Roche, GlaxoSmithKline, Janssen, and Zydus.

Mr. Vinay Sharma, promoted to Director - Rare Diseases Business Unit, has been the Rare Disease Business Unit Head since July 2024. He is a healthcare business leader with expertise in strategic launches and franchise building. His career includes leadership roles at AstraZeneca Philippines and nearly a decade at Novartis India. He holds a Bachelor's degree in Pharmacy and an Executive MBA from the Indian Institute of Management Calcutta.

Appointment Details

The following table summarizes the key details of the appointments and promotion:

These appointments are classified as Senior Management Personnel (SMP) positions under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company disclosed that there are no relationships between these directors that require disclosure under the relevant regulations.

AstraZeneca Pharma India has appointed Praveen K Mittal as Director - Corporate Affairs, effective July 6, 2026, strengthening its senior management leadership. The appointment was approved by the Board of Directors based on the recommendation of the Nomination and Remuneration Committee, and is classified as a full-time position. This strategic move aims to leverage Mittal's extensive experience in corporate affairs, government relations, and public policy to drive the company's stakeholder engagement and policy advocacy initiatives.

Appointment Details

The company disclosed the appointment under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The position is classified as Senior Management Personnel, necessitating detailed disclosures as per SEBI Circular No. HO/49/14/14(7)2025 - CFD-POD2/I/3762/2026 dated January 30, 2026. The term of the appointment is full-time employment, commencing from the specified effective date.

Profile of the Appointee

Praveen Kumar Mittal is a seasoned leader with nearly 30 years of experience across healthcare, medical technology, trade promotion, and industry advocacy. Prior to this role, he served as the Executive Director of the Export Promotion Council for Medical Devices (EPCMD), where he was responsible for policy advocacy, stakeholder engagement, and international market development. Before his tenure at EPCMD, he spent over 18 years with the Federation of Indian Chambers of Commerce & Industry (FICCI), most recently as Assistant Secretary General and Head of the Healthcare Division.

Key Professional Highlights

Mittal has played a pivotal role in establishing industry platforms and building strategic partnerships across government and industry. He was also instrumental in the establishment of the Ayush Export Promotion Council (AYUSHEXCIL), where he served as Honorary Director. His deep expertise in public policy and government engagement is supported by extensive international exposure across North America, Europe, and Asia.